(Q38062506)

28 August 2017

1 reference

title

Complexity of cancer stem cells (English)

1 reference

28 August 2017

neoplastic stem cells

1 reference

Eiji Sugihara

1

1 reference

PubMed ID

23180591

28 August 2017

Hideyuki Saya

series ordinal

2

1 reference

PubMed ID

23180591

28 August 2017

language of work or name

English

0 references

publication date

17 December 2012

1 reference

International Journal of Cancer

28 August 2017

1 reference

28 August 2017

132

1 reference

28 August 2017

6

1 reference

28 August 2017

1249-1259

1 reference

The clonal evolution of tumor cell populations

28 August 2017

1 reference

Stem cell concepts renew cancer research

21 January 2018

1 reference

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

Heterogeneity of clonogenic cells in acute myeloblastic leukemia

21 January 2018

1 reference

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

21 January 2018

1 reference

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma

21 January 2018

1 reference

Identification of cells initiating human melanomas

21 January 2018

1 reference

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells

21 January 2018

1 reference

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

21 January 2018

1 reference

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.

21 January 2018

1 reference

Stem cell gene expression programs influence clinical outcome in human leukemia.

21 January 2018

1 reference

MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.

21 January 2018

1 reference

Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.

21 January 2018

1 reference

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

21 January 2018

1 reference

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

21 January 2018

1 reference

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line

21 January 2018

1 reference

Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples

21 January 2018

1 reference

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

The role of human aldehyde dehydrogenase in normal and cancer stem cells

21 January 2018

1 reference

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

21 January 2018

1 reference

High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.

21 January 2018

1 reference

Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival

21 January 2018

1 reference

Cancer stem cells in solid tumors: elusive or illusive?

21 January 2018

1 reference

Current strategies for identification of glioma stem cells: adequate or unsatisfactory?

21 January 2018

1 reference

Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas

21 January 2018

1 reference

Leukaemia stem cells and the evolution of cancer-stem-cell research.

21 January 2018

1 reference

Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

21 January 2018

1 reference

Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.

21 January 2018

1 reference

In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties

21 January 2018

1 reference

Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor.

21 January 2018

1 reference

Cells of origin in cancer

21 January 2018

1 reference

Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL.

21 January 2018

1 reference

A tumorigenic subpopulation with stem cell properties in melanomas

21 January 2018

1 reference

Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

21 January 2018

1 reference

Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

21 January 2018

1 reference

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells

21 January 2018

1 reference

Efficient tumour formation by single human melanoma cells

21 January 2018

1 reference

Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized

21 January 2018

1 reference

Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas

21 January 2018

1 reference

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth

21 January 2018

1 reference

The cancer stem cell niche--there goes the neighborhood?

21 January 2018

1 reference

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis

21 January 2018

1 reference

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

Stemness, cancer and cancer stem cells

21 January 2018

1 reference

c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.

21 January 2018

1 reference

Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells

21 January 2018

1 reference

Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells.

21 January 2018

1 reference

Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12

21 January 2018

1 reference

PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2

21 January 2018

1 reference

TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells

21 January 2018

1 reference

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

21 January 2018

1 reference

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

21 January 2018

1 reference

CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth

21 January 2018

1 reference

PML targeting eradicates quiescent leukaemia-initiating cells

21 January 2018

1 reference

TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia

21 January 2018

1 reference

Making a tumour's bed: glioblastoma stem cells and the vascular niche.

21 January 2018

1 reference

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

21 January 2018

1 reference

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

21 January 2018

1 reference

Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers

21 January 2018

1 reference

Epigenetics and the plasticity of differentiation in normal and cancer stem cells

21 January 2018

1 reference

A decade of exploring the cancer epigenome - biological and translational implications

21 January 2018

1 reference

Cancer epigenetics reaches mainstream oncology

21 January 2018

1 reference

Genetic variegation of clonal architecture and propagating cells in leukaemia

21 January 2018

1 reference

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.

21 January 2018

1 reference

Cancer stem cells: impact, heterogeneity, and uncertainty

21 January 2018

1 reference

A Quantitative Assay for the Number of Murine Lymphoma Cells capable of Proliferation in vivo

21 January 2018

1 reference

Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27961

1 reference

28 August 2017

1 reference

PubMed ID

23180591